Key genes and molecular mechanisms related to Paclitaxel Resistance
Cancer Cell International · 13.07.2024 · 24 (1)
DOI: 10.1186/s12935-024-03415-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell International, online erschienen am 13.07.2024. Verfasst von Adel I Alalawy. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk, 71491, Saudi Arabia. aalalawy@ut.edu.sa. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Paclitaxel is commonly used to treat breast, ovarian, lung, esophageal, gastric, pancreatic cancer, and neck cancer cells. Cancer recurrence is observed in patients treated with paclitaxel due to paclitaxel resistance emergence. Resistant mechanisms are observed in cancer cells treated with paclitaxel, docetaxel, and cabazitaxel including changes in the target molecule β-tubulin of mitosis, molecular mechanisms that activate efflux drug out of the cells, and alterations in regulatory proteins of apoptosis. This review discusses new molecular mechanisms of taxane resistance, such as overexpression of genes like the multidrug resistance genes and EDIL3 , ABCB1 , MRP1 , and TRAG-3/CSAG2 genes. Moreover, significant lncRNAs are detected in paclitaxel resistance, such as lncRNA H19 and cross-resistance between taxanes. This review contributed to discovering new treatment strategies for taxane resistance and increasing the responsiveness of cancer cells toward chemotherapeutic drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk, 71491, Saudi Arabia. aalalawy@ut.edu.sa.
Zitieren
APA
Alalawy, A. I. (2024). Key genes and molecular mechanisms related to Paclitaxel Resistance. Cancer Cell International, 24(1). https://doi.org/10.1186/s12935-024-03415-0
Vancouver
Alalawy AI. Key genes and molecular mechanisms related to Paclitaxel Resistance. Cancer Cell International. 2024;24(1). doi:10.1186/s12935-024-03415-0
BibTeX
@article{Alalawy2024,
author = {Alalawy, Adel I},
title = {Key genes and molecular mechanisms related to Paclitaxel Resistance},
journal = {Cancer Cell International},
year = {2024},
volume = {24},
number = {1},
doi = {10.1186/s12935-024-03415-0}
}
EUVIMED